Literature DB >> 2203346

Tissue-specific expression of rat pyruvate kinase L/chloramphenicol acetyltransferase fusion gene in transgenic mice and its regulation by diet and insulin.

K Yamada1, T Noguchi, J Miyazaki, T Matsuda, M Takenaka, K Yamamura, T Tanaka.   

Abstract

We produced transgenic mice carrying about 3 kb of the 5'-flanking sequence of the rat pyruvate kinase L gene linked to the chloramphenicol acetyltransferase (CAT) structural gene. Expression of the transgene was observed only in tissues in which the endogenous L-type pyruvate kinase is expressed. Dietary glucose or insulin induced similar increases in the levels of CAT and L-type pyruvate kinase mRNAs in the liver. However, the fructose-induced level of CAT mRNA was about 3- and 6- fold lower than those of endogenous L-type pyruvate kinase mRNA in the liver and kidney, respectively, confirming our previous finding that stabilization of the transcripts of the pyruvate kinase L gene is an important regulatory step in fructose induction, especially in the kidney. Thus we conclude that all the cis-acting elements responsible for tissue-specific expression of the L-type pyruvate kinase and its stimulation by dietary components and insulin are localized in the sequence from about nucleotide -3000 to +37 in the pyruvate kinase L gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203346     DOI: 10.1016/0006-291x(90)91383-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP.

Authors:  M O Bergot; M J Diaz-Guerra; N Puzenat; M Raymondjean; A Kahn
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

Review 2.  Regulation of gene expression by insulin.

Authors:  R M O'Brien; D K Granner
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

3.  Members of the nuclear factor 1 family and hepatocyte nuclear factor 4 bind to overlapping sequences of the L-II element on the rat pyruvate kinase L gene promoter and regulate its expression.

Authors:  K Yamada; T Tanaka; T Noguchi
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 4.  Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver.

Authors:  F P Lemaigre; G G Rousseau
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  Functional synergism in the carbohydrate-induced activation of liver-type pyruvate kinase gene expression.

Authors:  Z Liu; H C Towle
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

6.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Authors:  Timothy D Wiggin; Matthias Kretzler; Subramaniam Pennathur; Kelli A Sullivan; Frank C Brosius; Eva L Feldman
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

7.  Elements responsible for hormonal control and tissue specificity of L-type pyruvate kinase gene expression in transgenic mice.

Authors:  M H Cuif; M Cognet; D Boquet; G Tremp; A Kahn; S Vaulont
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

Review 8.  Nutrient and hormonal regulation of pyruvate kinase gene expression.

Authors:  K Yamada; T Noguchi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

9.  Mutational mimics of allosteric effectors: a genome editing design to validate allosteric drug targets.

Authors:  Qingling Tang; Maria T Villar; Antonio Artigues; John P Thyfault; Udayan Apte; Hao Zhu; Kenneth R Peterson; Aron W Fenton
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

10.  PKM2 regulates endothelial cell junction dynamics and angiogenesis via ATP production.

Authors:  Jesús Gómez-Escudero; Cristina Clemente; Diego García-Weber; Rebeca Acín-Pérez; Jaime Millán; José A Enríquez; Katie Bentley; Peter Carmeliet; Alicia G Arroyo
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.